RFT-5-dgA in Patients With Metastatic Melanoma

NCT00314093 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

DRUG: RFT5pdgA

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]